Bottom line
IYH vs JDOC: the short answer
IYH (iShares U.S. Healthcare ETF) and JDOC (JPMorgan Healthcare Leaders ETF) share a meaningful slice of their top holdings — about 60% by weight.
IYH is cheaper at 0.37% vs 0.65% — a difference of $28 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +13.1% for IYH.
Updated Nov 19, 2026
IYH vs JDOC side by side
| IYH | JDOC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.65% |
| Annual cost per $10k | $37 | $65 |
| 10-yr cost on $10k (prospectus) | $468 | $810 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +13.1% | +14.9% |
| 5-yr return (annualized) | +7.0% | — |
| 10-yr return (annualized) | +9.4% | — |
| Best quarter | +15.3% | +11.3% |
| Worst quarter | −12.7% | −11.9% |
| Net assets (fund) | $3.6B | $9.1M |
| Number of holdings | 103 | 61 |
| Portfolio turnover | 3% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IYH | JDOC | Difference |
|---|---|---|---|
| 2025 | +13.1% | +14.9% | −1.8% |
| 2024 | +3.1% | −0.6% | +3.7% |
Source: Fund prospectus bar charts
Holdings overlap
13 of IYH's top 25 holdings also appear in JDOC's top 25.
| Holding | IYH | JDOC |
|---|---|---|
| Eli Lilly And Company | 15.11% | 7.76% |
| Johnson & Johnson | 10.17% | 4.82% |
| Abbvie Inc. | 7.32% | 7.85% |
| Unitedhealth Group Incorporated | 6.16% | 5.85% |
| Merck & Co., Inc. | 5.31% | 4.82% |
| Thermo Fisher Scientific Incorporated | 3.52% | 3.73% |
| Abbott Laboratories | 3.02% | 3.11% |
| Bristol-myers Squibb Company | 2.20% | 3.57% |
| Intuitive Surgical, Inc. | 2.05% | 1.93% |
| Danaher Corporation | 2.03% | 2.16% |
| Stryker Corporation | 1.86% | 2.23% |
| Regeneron Pharmaceuticals, Inc. | 1.27% | 1.60% |
| Edwards Lifesciences Corporation | 0.81% | 1.73% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between IYH and JDOC?
Which is cheaper, IYH or JDOC?
Should I own both IYH and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.